Characterization and Functional Analysis of the Promoter for the Human Equilibrative Nucleoside Transporter Gene, hENT1

REFERENCES

• Baldwin , S.A. , Beal , P.R. , Yao , S.Y.M. , King , A.E. , Cass , C.E. and Young , J.D. 2004 . The equilibrative nucleoside transporter family, SLC29 . Pflugers Arch.—Eur. J. Physiol. , 447 : 735 – 743 .
   PubMed Web of Science ®Google Scholar
• Gray , J.H. , Owen , R.P. and Giacomini , K.M. 2004 . The concentrative nucleoside transporter family. SLC28 . Pflugers Arch.—Eur. J. Physiol. , 447 : 728 – 734 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wright , A. , Gati , W. and Paterson , A.R. 2000 . Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport . Leukemia , 1 : 52 – 60 . [CROSSREF] [CSA]
   Google Scholar
• Jeha , S. , Gandhi , V. , Chan , K.W. , McDonald , L. , Ramirez , I. , Madden , R. , Rytting , M. , Brandt , M. , Keating , M. , Plunkett , W. and Kantarjian , H. 2004 . Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia . Blood , 103 : 784 – 789 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Tempero , M. , Plunkett , W. , Ruiz Van Haperen , V. , Hainsworth , J. , Hochster , H. , Lenzi , R. and Abbruzzese , J. 2003 . Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma . J. Clin. Oncol. , 21 : 3402 – 3408 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Pennycooke , M. , Chaudary , N. , Shuralyova , I. , Zhang , Y. and Coe , I. 2001 . Differential expression of human nucleoside transporters in normal and tumor tissue . BBRC , 280 : 951 – 959 . [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Farré , X. , Guillén-Gómez , H. , Sánchez , L. , Hardisson , D. , Plaza , Y. , Lloberas , J. , Casado , F.J. , Palacios , J. and Pastor-Anglada , M. 2004 . Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors . Int. J. Cancer. , 112 : 959 – 966 . [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Mackey , J.R. , Jennings , L.L. , Clarke , M.L. , Santos , C.L. , Dabbagh , L. , Vsianska , M. , Koski , S.L. , Coupland , R.W. , Baldwin , S.A. , Young , J.D. and Cass , C.E. 2002 . Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers . Clin. Cancer Res. , 8 : 110 – 116 . [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Mackey , J.R. , Galmarini , C.M. , Graham , K.A. , Joy , A.A. , Delmer , A. , Dabbaugh , L. , Glubrecht , D. , Jewell , L.D. , Lai , R. , Lang , T. , Young , J.D. , Merle-Béral , H. , Binet , J.L. and Cass , C.E. 2005 . Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): Identification of fludarabine-sensitive and -insensitive populations . Blood , 105 : 767 – 774 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Chaudary , N. , Naydenova , Z. , Shuralyova , I. and Coe , I.R. 2004 . Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1 . Cardiovas. Res. , 61 : 780 – 788 . [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Eltzschig , H.K. , Abdulla , P. , Hoffman , E. , Hamilton , K.E. , Daniels , D. , Schönfeld , C. , Löffler , M. , Reyes , G. , Duszenko , M. , Karhausen , J. , Robinson , A. , Westerman , K.A. , Coe , I.R. and Colgan , S.P. 2005 . HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia . J. Exp. Med. , 202 : 1493 – 1505 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Archer , R.G. and Pitelka , V. 2004 . Hammond, J.R. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells . Br. J. Pharmacol. , 143 : 202 – 214 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Soler , C. , Felipe , A. , Garcia-Manteiga , J. , Serra , M. , Guillen-Gomez , E. , Casado , F.J. , MacLeod , C. , Modolell , M. , Pastor-Anglada , M. and Celada , A. 2003 . Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways . Biochem. J. , 375 : 777 – 783 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMedGoogle Scholar
• Lu , H. , Chen , C. and Klaassen , C. 2004 . Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice . Drug Metabol. Dispos. , 32 : 1455 – 1461 . [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Coe , I.R. , Griffiths , M. , Young , J.D. , Baldwin , S.A. and Cass , C.E. 1997 . Assignment of the human equilibrative nucleoside transporter (hENT1) to 6p21.1-p21.2 . Genomics , 45 : 459 – 460 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMedGoogle Scholar
• Sankar , N. , Machado , J. , Abdulla , P. , Hilliker , A.J. and Coe , I.R. 2002 . Comparative genomic analysis of equilibrative nucleoside transporters suggests conserved protein structure despite limited sequence identity . Nucleic Acids Research. , 30 : 4339 – 4350 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMedGoogle Scholar
• Goh , L.-B. and Lee , C.-W. 1997 . Reduction of equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter in tamoxifen-treated MCF-7 cells: An oestrogen-reversible phenomenon . Biochem. J. , 327 : 31 – 36 . [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Galmarini , C.M. , Thomas , X. , Calvo , F. , Rousselot , P. , Rabilloud , M. , El Jaffari , A. , Cros , E. and Dumontet , C. 2002 . In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia . Br. J. Haematol. , 117 : 860 – 868 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Galmarini , C.M. , Thomas , X. , Calvo , F. , Rousselot , P. , El Jafari , A. , Cros , E. and Dumontet , C. 2002 . Potential mechanisms of resistance to cytarabine in AML patients . Leuk. Res. , 26 : 621 – 629 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Choi , D.-S. , Handa , H. , Young , H. , Gordon , A.S. , Diamond , I. and Messing , R.O. 2000 . Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene . BBRC , 277 : 200 – 208 . [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Semenza , G.L. 2000 . HIF-1: Using two hands to flip the angiogenic switch . Cancer Metastasis Rev , 19 : 59 – 65 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Comerford , K.M. , Wallace , T.J. , Karhausen , J. , Louis , N.A. , Montalto , M.C. and Colgan , S.P. 2002 . Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene . Cancer Res. , 62 : 3387 – 3394 . [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Boleti , H. , Coe , I.R. , Baldwin , S. , Young , J. and Cass , C.E. 1997 . Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells . Neuropharmacology , 36 : 1167 – 1179 . [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar